US · Health Care
Humana (HUM) stock research: earnings, ownership, and cash flow
Humana operates in the Managed Health Care industry within the Health Care sector and is a constituent of the S&P 500. This page connects filing evidence with ownership, insider activity, forecasts, ETFs, and peer context so each dataset can be checked against the others.
Deterministic, source-linked commentary
What the latest evidence says about HUM
Humana's latest filing sets the operating baseline. 10-Q covers CY2026Q1. quarterly revenue was $39.6B; year-over-year growth was 23.5%; operating margin was 4.4%; trailing free cash flow was $1.9B. Read together, these figures test whether scale is translating into profit and cash. Verify periods and company footnotes in the original SEC EDGAR filing.
No single dataset settles the HUM research case. Use institutional ownership, insider filings alongside the filing. Company facts can update before 13F positions, so align every source date and report period before treating a difference as a change in fundamentals.
Business model
Company snapshot
Humana operates in the Managed Health Care industry within the Health Care sector and is a constituent of the S&P 500. The latest standardized snapshot records $136.8B of trailing revenue, $3.17B of net income, and $1.85B of free cash flow. These figures describe the reported company, while valuation and price require a separate market-data timestamp.
Operating lines
A named product, service, or operating exposure identified in the company description.
A named product, service, or operating exposure identified in the company description.
Geographic revenue mix
The current standardized filing dataset does not extract a comparable geographic revenue table for every issuer. Review the latest 10-K segment note for domestic and international mix, concentration, foreign-exchange sensitivity, and country-specific regulation.
10-Q · 2026-04-29
What the latest filing shows
Revenue for the latest standardized quarter was $39.65B, while diluted EPS was 9.83. Revenue changed 23.5% from the comparable period. Gross margin was N/A and operating margin was 4.4%. Margin direction matters because it shows whether growth is translating into operating leverage or requiring more cost to support.
Open original SEC filingCY2026Q1
Earnings analysis
| Period | Revenue | Net income | EPS | Operating margin |
|---|---|---|---|---|
| CY2026Q1 | $39.65B | $1.19B | 9.83 | 4.4% |
| TTM | $136.8B | $3.17B | 26.26 | 3.8% |
| CY2025 | $129.66B | $1.19B | See filing | 2.1% |
The standardized data shows revenue growth of 23.5%, an operating margin of 3.8%, and a net margin of 2.3%. Without a dedicated earnings article, the original filing remains the primary source for management guidance and expectation comparisons.
Health Care
Peer comparison
| Company | TTM revenue | Revenue growth | Operating margin | Tracked holders |
|---|---|---|---|---|
| HUMHumana | $136.8B | 23.5% | 3.8% | 0 |
| CNCCentene Corporation | $174.51B | 5.1% | -2.3% | 0 |
| PFEPfizer | $100.08B | -6% | N/A | 0 |
| ELVElevance Health | $199.56B | 2.6% | 4.5% | 0 |
| JNJJohnson & Johnson | $93.69B | 9.9% | 26% | 0 |
| CVSCVS Health | $236.35B | 36.6% | 3.1% | 0 |
| CAHCardinal Health | $239.78B | 18.8% | 1.1% | 0 |
HUM's 23.5% revenue growth and 3.8% operating margin should be read against peers using the same reporting definitions. A higher margin may reflect pricing power or business mix, while a lower margin can reflect investment, cyclicality, or weaker economics.
Fund ownership
ETF exposure
HUM appears among the disclosed top holdings of 1 tracked ETFs shown below. ETF weights change with price movement, rebalancing, creations, redemptions, and issuer methodology.
| ETF | HUM weight | AUM | Holdings date |
|---|---|---|---|
| RSPInvesco S&P 500 Equal Weight ETF | 0.35% | $86.11B | May 18, 2026 |
10-K · 2026-02-19
Key risk factors disclosed in the latest 10-K
The categories below are a deterministic research checklist anchored to Humana's industry and latest annual filing. They summarize areas investors should locate in Item 1A; they do not replace the company's exact legal disclosure.
- Demand and product-cycle risk: Managed Health Care can experience changing customer demand, replacement cycles, and competitive product launches that affect revenue timing.
- Competition and execution: Market share depends on product quality, pricing, distribution, innovation, and management's ability to convert investment into durable customer demand.
- Supply chain and counterparties: Supplier concentration, logistics disruption, component availability, and customer concentration can affect delivery schedules, costs, and working capital.
- Regulation and litigation: Antitrust, privacy, securities, labor, tax, environmental, and industry-specific rules may change costs or restrict products and business practices.
- Financial and market risk: Foreign exchange, interest rates, credit conditions, investment values, and capital-allocation decisions can affect reported earnings and valuation.
Shareholder returns
Dividend and buyback history
Dividend
Humana reported $432M of dividends paid over the trailing period and $107M in the latest standardized quarter. These are company cash outflows, not a per-share forward yield.
Share buybacks
The standardized snapshot does not currently expose a reliable repurchase authorization and share-count bridge for every issuer. Compare diluted shares outstanding across filings and read the capital-return note before concluding that buybacks reduced the share base.
Research workflow
Common research questions about HUM
Who is the largest tracked institutional holder of HUM?
The current tracked-manager sample does not identify an active HUM holder. The HUM ownership page will reflect a matching position when one enters the filing dataset.
What does recent insider activity show for HUM?
No recent Form 4 transaction appears in the current HUM window. Check the HUM Form 4 history for later company-officer or director filings.
What business does Humana operate?
Humana operates in the Managed Health Care industry within the Health Care sector and is a constituent of the S&P 500. The HUM company snapshot connects that business description with reported revenue, profit, and cash flow.
How does HUM compare with a close operating peer?
HUM's revenue growth is 23.5% and its operating margin is 3.8%. Compare those figures with CNC research using the same definitions.
What do the latest financials say about HUM?
10-Q reports $136.8B of trailing revenue, with revenue growth of 23.5% and an operating margin of 3.8%. The supporting period and source are listed in the HUM filing section.
How strong is HUM's cash return profile?
Humana reported $432.0M of trailing dividends paid alongside $1.9B of free cash flow. The HUM capital-return section separates company cash outflows from a forward per-share yield.
Which reported changes matter most for the HUM outlook?
Without a dedicated forecast, the key HUM evidence is the direction of revenue, margin, cash flow, and company guidance. The HUM earnings section keeps those reported changes together.
Primary and reference data
Sources and methodology
- Filings: SEC EDGAR CompanyFacts, 10-K, 10-Q, 8-K, Form 4, 13F-HR.
- Fundamentals: SEC EDGAR CompanyFacts; market references may use yfinance and Finnhub where explicitly available.
- ETF: Issuer disclosures and the locally dated ETF holdings snapshot.
Methodology: How SnowballHare parses and validates data.
Editorial standards: How research is published.
Disclaimer: Informational only; not investment, legal, or tax advice. Cross-check material facts against original filings before acting.
Reference notes
Data notes
Reporting dates
Use filing dates, report periods, and source links together for HUM. A company filing, a 13F disclosure, a Form 4 transaction, and an earnings release can describe different time windows, so the date beside each row matters before comparing signals.
Ownership context
13F rows are delayed public long-equity snapshots from a selected manager universe. They are useful for seeing which tracked institutions reported exposure, but they do not show every hedge, short position, cash balance, or trade made after the quarter ended.
Insider transactions
Form 4 activity should be read by transaction type, role, value, and remaining ownership. Open-market purchases and sales are different from grants, option exercises, gifts, or tax withholding, and the original SEC filing is still the controlling document.
Earnings and forecasts
Earnings pages and forecast pages are linked when a supported article exists. Treat those pages as context for reported numbers, guidance, margins, and scenario assumptions, then return to the table data when you need the underlying source date or filing trail.